Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1314-1323

  Sherry, Barbara ^a   Torres, Johann ^a   Blum, Mary Ann ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CORE PROTEIN; INTERFERON ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; INTERFERON INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REOVIRUS; VIRUS CORE; VIRUS GENE; VIRUS MYOCARDITIS;

EID: 0031882107     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1314-1323.1998     Document Type: Article

References (72)

1. Aretz, H. T., M. E. Billingham, W. D. Edwards, S. M. Factor, J. T. Fallon, J. J. Fenoglio, E. G. J. Olsen, and F. J. Schoen. 1986. Myocarditis: a histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1:3-14.
2. Baglioni, C., A. De Benedetti, and G. J. Williams. 1984 Cleavage of nascent reovirus mRNA by localized activation of the 2′-5′-oligoadenylate-dependent endoribonuclease. J. Virol. 52:865-871.
3. Baty, C. J., and B. Sherry. 1993. Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis. J. Virol. 67:6295-6298.
4. Beattie, E., K. L. Denzler, J. Tartaglia, M. E. Perkus, E. Paolettie, and B. L. Jacobs. 1995. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:499-505.
5. Bischoff, J. R., and C. E. Samuel. 1989. Mechanism of interferon action. Activation of the human P1/eIF-2 alpha protein kinase by individual reovirus s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA. Virology 172:106-115.
6. Blau, H. M., C. Choy-Pik, and C. Webster. 1983. Cytoplasmic activation of human nuclear genes in stable heterokaryons. Cell 32:1171-1180.
7. Brentano, L., D. Noah, E. G. Brown, and B. Sherry. The reovirus protein mu 2, encoded by the M1 gene, is an RNA-binding protein. Submitted for publication.
8. Chow, L. H., K. W. Beisel, and B. M. McManus. 1992. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab. Invest. 66:24-31.
9. Cleveland, D. R., H. Zarbl, and S. Millward. 1986. Reovirus guanylyltransferase is L2 gene product lambda 2 protein. J. Virol. 60:307-311.
10. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-1585.
11. Coombs, K. 1996. Identification and characterization of a double-stranded RNA reovirus temperature-sensitive mutant defective in minor core protein mu2. J. Virol. 70:4237-4245.
12. De Benedetti, A., G. J. Williams, L. Comeau, and C. Baglioni. 1985. Inhibition of viral mRNA translation in interferon-treated L cells infected with reovirus. J. Virol. 55:588-593.
13. De Castro, S., G. D'Amati, P. Gallo, D. Cartoni, P. Santopadre, V. Vullo, A. Cirelli, and G. Migliau. 1994. Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J. Am. Coll. Cardiol. 24:1018-1024.
14. Dermody, T. S., L. A. Schiff, M. L. Nibert, K. M. Coombs, and B. N. Fields. 1991. The S2 gene nucleotide sequences of prototype strains of the three reovirus serotypes: characterization of reovirus core protein σ2. J. Virol. 65:5721-5731.
15. Drayna, D., and B. N. Fields. 1982. Activation and characterization of the reovirus transcriptase: genetic analysis. J. Virol. 41:110-118.
16. Dryden, J. A., G. Wang, M. Yeager, M. L. Nibert, K. M. Coombs, D. B. Furlong, B. N. Fields, and T. S. Baker. 1993. Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J. Cell Biol. 122:1023-1041.
17. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell 84:443-450.
18. Ellis, M. N., C. S. Eidson, J. Brown, and S. H. Kleven. 1983. Studies on the interferon induction and interferon sensitivity of avian reoviruses. Avian Dis. 27:927-936.
19. Farsetta, D. L., K. A. Dryden, and M. L. Nibert. 1996. Identification of three proteins in reovirus top component particles that contribute to an internal structure seen by cryo-electron microscopy and image reconstruction, abstr. W10-9. In Scientific program and abstracts. American Society for Virology annual meeting.
20. Gresser, I., M. G. Tovey, C. Maury, and M.-T. Bandu. 1976. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J. Exp. Med. 144:1316-1322.
21. Gupta, S. L., S. L. Holmes, and L. L. Mehra. 1982. Interferon action against reovirus: activation of interferon-induced protein kinase in mouse L929 cells upon reovirus infection. Virology 120:495-499.
22. Hassan, S. A., E. R. Rabin, and J. L. Melnick. 1965. Reovirus myocarditis in mice: an electron microscopic, immunofluorescent, and virus assay study. Exp. Mol. Pathol. 4:66-80.
23. Herzum, M., V. Ruppert, B. Kuytz, H. Jomaa, I. Nakamura, and B. Maisch. 1994. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J. Mol. Cell. Cardiol. 26:907-913.
24. Hiscott, J., H. Nguyen, and R. Lin. 1995. Molecular mechanisms of interferon beta gene induction. Semin. Virol. 6:161-174.
25. Imani, F., and B. Jacobs. 1988. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA 85:7887-7891.
26. Jacobs, B. L., and R. E. Ferguson. 1991. The Lang strain of reovirus serotype 1 and the Dearing strain of reovirus serotype 3 differ in their sensitivities to beta Interferon. J. Virol. 65:5102-5104.
27. Jacobs, B. L., and J. O. Langland. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349.
28. Kibler, K. V., T. Shors, K. B. Perkins, C. C. Zeman, M. P. Banaszak, J. Biesterfeldt, J. O. Langland, and B. L. Jacobs. 1997. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71:1992-2003.
29. Lai, M.-H. T., and W. K. Joklik. 1973. The induction of interferon by temperature-sensitive mutants of reovirus. UV-irradiated reovirus, and subviral reovirus particles. Virology 51:191-204.
30. Levy, D. E. 1995. Interferon induction of gene expression through the JAK-STAT pathway. Semin. Virol. 6:181-190.
31. Lewis, J. A. 1988. Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo(A) synthetase and eIF-2 kinase. Virology 162:118-127.
32. Lloyd, R. M., and A. J. Shatkin. 1992. Translational stimulation by reovirus polypeptide σ3: substitution for VAI RNA and inhibition of phosphorylation of the α subunit of eukaryotic initiation factor 2. J. Virol. 66:6878-6884.
33. Long, W. F., and D. C. Burke. 1971. Interferon production by double-stranded RNA: a comparison of interferon induction by reovirus RNA to that by a synthetic double-stranded polynucleotide. J. Gen. Virol. 12:1-11.
34. Mao, Z. X., and W. K. Joklik. 1991. Isolation and enzymatic characterization of protein lambda 2, the reovirus guanylyltransferase. Virology 185:377-386.
35. Martin, A., S. Webber, F. Flicker, R. Jaffe, G. Demmler, D. Kearney, Y.-H. Zhang, J. Bodurtha, B. Gelb, J. Ni, T. Bricker, and J. A. Towbin. 1994. Acute myocarditis: rapid diagnosis by PCR in children. Circulation 90:330-339.
36. Martino, T. A., P. Liu, and M. J. Sole. 1994. Viral infection and pathogenesis of dilated cardiomyopathy. Circ. Res. 74:182-188.
37. Mason, J. W., J. B. O'Connell, A. Herskowitz, N. R. Rose, B. M. McManus, M. E. Billingham, T. E. Moon, and Myocarditis Treatment Trial Investigators. 1995. A clinical trial of immunosuppressive therapy for myocarditis. N. Engl. J. Med. 333:269-275.
38. Matoba, Y., B. Sherry, B. N. Fields, and T. W. Smith. 1991. Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells. J. Clin. Invest. 87:1628-1633.
39. Meraz, M. A., J. M. White, K. C. F. Sheehan, E. A. Bach, S. C. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signalling pathway. Cell 84:431-442.
40. Metcalf, P., M. Cyrklaff, and M. Adrian. 1991. The three-dimensional structure of reovirus obtained by cryo-electron microscopy. EMBO J. 10:3129-3136.
41. Miyamoto, N. G., B. L. Jacobs, and C. E. Samuel. 1983. Mechanism of interferon action. Effect of double-stranded RNA and the 5′-O-monophosphate form of 2′,5′-oligoadenylate on the inhibition of reovirus mRNA translation in vitro. J. Biol. Chem. 258:15232-15237.
42. Muller, U., U. Steinhoff, L. F. L. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
43. Munemitsu, S. M., and C. E. Samuel. 1984. Biosynthesis of reovirus-specified polypeptides. Multiplication rate but not yield of reovirus serotypes 1 and 3 correlates with the level of virus-mediated inhibition of cellular protein synthesis. Virology 136:133-143.
44. Nibert, M. L., L. A. Schiff, and B. N. Fields. 1996. Reoviruses and their replication, p. 1557-1596. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
45. Nilsen, T. W., P. A. Maroney, and C. Baglioni. 1982. Inhibition of protein synthesis in reovirus-infected HeLa cells with elevated levels of interferon-induced protein kinase activity. J. Biol. Chem. 257:14593-14596.
46. Nilsen, T. W., P. A. Maroney, and C. Baglioni. 1982. Synthesis of (2′-5′)oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J. Virol. 42:1039-1045.
47. Noble, S., and M. L. Nibert. 1997. Core protein μ2 is a second determinant of nucleoside triphosphatase activities by reovirus cores. J. Virol. 71:7728-7735.
48. Oberhaus, S. M., R. L. Smith, G. H. Clayton, T. S. Dermody, and K. L. Tyler. 1997. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J. Virol. 71:2100-2106.
49. Rabin, E. R., S. A. Hassan, A. B. Jenson, and J. L. Melnick. 1964. Coxsackievirus B3 myocarditis in mice. An electron microscopic, immunofluorescent and virus-assay study. Am. J. Pathol. 44:775-797.
50. Rodgers, S. E., E. S. Barton, S. M. Oberhaus, B. Pike, C. A. Gibson, K. L. Tyler, and T. S. Dermody. 1997. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J. Virol. 71:2540-2546.
51. Rose, N. R., and S. L. Hill. 1996. The pathogenesis of postinfectious myocarditis. Clin. Immunol. Immunopathol. 80:S92-S99.
52. Samuel, C. E. 1993. The eIF-2alpha protein kinases, regulators of translation in eukaryotes from yeast to humans. J. Biol. Chem. 268:7603-7606.
53. Samuel, C. E., R. Duncan, G. S. Knutson, and J. W. Hershey. 1984. Mechanism of interferon action. Increased phosphorylation of protein synthesis initiation factor eIF-2 alpha in interferon-treated reovirus-infected mouse L929 fibroblasts in vitro and in vivo. J. Biol. Chem. 259:13451-13457.
54. Samuel, C. E., and G. S. Knutson. 1982. Mechanism of interferon action. Kinetics of decay of the antiviral state and protein phosphorylation in mouse fibroblasts treated with natural and cloned interferons. J. Biol. Chem. 257: 11796-11801.
55. Schmechel, S., M. Chute, P. Skinner, R. Anderson, and L. Schiff. 1997. Preferential translation of reovirus mRNA by a sigma 3-dependent mechanism. Virology 232:62-73.
56. Sharpe, A. H., and B. N. Fields. 1982. Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology 122:381-391.
57. Sherry, B., C. J. Baty, and M. A. Blum. 1996. Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J. Virol. 70:6709-6715.
58. Sherry, B., and M. A. Blum. 1994. Multiple viral core proteins are determinants of reovirus-induced acute myocarditis. J. Virol. 68:8461-8465.
59. Sherry, B., and B. N. Fields. 1989. The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J. Virol. 63:4850-4856.
60. Sherry, B., X.-Y. Li, K. L. Tyler, J. M. Cullen, and H. W. Virgin IV. 1993. Lymphocytes protect against and are not required for reovirus-induced myocarditis. J. Virol. 67:6119-6124.
61. Sherry, B., F. J. Schoen, E. Wenske, and B. N. Fields. 1989. Derivation and characterization of an efficiently myocarditic reovirus variant. J. Virol. 63: 4840-4849.
62. Sherry, B., and D. Cook. Unpublished data.
63. Stangl, E., W. Aschauer, J. Zahringer, and G. Hubner. 1987. Reovirus myocarditis. Eur. Heart J. 8(Suppl. J):407-409.
64. Starnes, M. C., and W. K. Joklik. 1993. Reovirus protein lambda 3 is a poly(C)-dependent poly(G) polymerase. Virology 193:356-366.
65. Steinhoff, U., U. Müller, A. Schertler, H. Hengartner, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J. Virol. 69: 2153-2158.
66. Tracy, S., N. M. Chapman, B. M. McManus, M. A. Pallansch, M. A. Beck, and J. Carstens. 1990. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J. Mol. Cell. Cardiol. 22:403-414.
67. Tyler, K. L., and B. N. Fields. 1996. Reoviruses, p. 1597-1624. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
68. Virgin, H. W., K. L. Tyler, and T. S. Dermody. 1997. Reovirus, p. 669-702. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, New York, N.Y.
69. Welsh, R. M., and G. Sen. 1997. Non-specific host responses to viral infection, p. 109-142. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, New York, N.Y.
70. Woodruff, J. F. 1980. Viral myocarditis, a review. Am. J. Pathol. 101:427-479.
71. Yin, P., M. Cheang, and K. M. Coombs. 1996. The M1 gene is associated with differences in the temperature optimum of the transcriptase activity in reovirus core particles. J. Virol. 70:1223-1227.
72. Yue, Z., and A. J. Shatkin. 1997. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. Virology 234:364-371.